Blue dye could save lives in sepsis? new trial launches
NCT ID NCT07264543
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests if a medicine called methylene blue can help improve blood flow in patients with septic shock, a severe infection that causes dangerously low blood pressure. About 50 adults will receive either methylene blue or standard care for 3 days. The main goal is to see if a larger trial is possible, not yet to prove the drug works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Irmandade da Santa Casa de Misericórdia de Curitiba
RECRUITINGCuritiba, Paraná, 80010-030, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••